- Home
- ATXG vs BDRX Comparison
ATXG vs BDRX Comparison
Compare ATXG & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- BDRX
- Stock Information
- Founded
- ATXG 2014
- BDRX 2000
- Country
- ATXG China
- BDRX United Kingdom
- Employees
- ATXG N/A
- BDRX N/A
- Industry
- ATXG Professional Services
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- BDRX Health Care
- Exchange
- ATXG Nasdaq
- BDRX Nasdaq
- Market Cap
- ATXG 3.8M
- BDRX 3.9M
- IPO Year
- ATXG N/A
- BDRX N/A
- Fundamental
- Price
- ATXG $1.01
- BDRX $7.64
- Analyst Decision
- ATXG
- BDRX
- Analyst Count
- ATXG 0
- BDRX 0
- Target Price
- ATXG N/A
- BDRX N/A
- AVG Volume (30 Days)
- ATXG 1.1M
- BDRX 25.1K
- Earning Date
- ATXG 11-13-2025
- BDRX 09-23-2025
- Dividend Yield
- ATXG N/A
- BDRX N/A
- EPS Growth
- ATXG N/A
- BDRX N/A
- EPS
- ATXG N/A
- BDRX N/A
- Revenue
- ATXG $4,310,835.00
- BDRX N/A
- Revenue This Year
- ATXG N/A
- BDRX N/A
- Revenue Next Year
- ATXG N/A
- BDRX N/A
- P/E Ratio
- ATXG N/A
- BDRX N/A
- Revenue Growth
- ATXG N/A
- BDRX N/A
- 52 Week Low
- ATXG $0.36
- BDRX $5.00
- 52 Week High
- ATXG $1.86
- BDRX $108.90
- Technical
- Relative Strength Index (RSI)
- ATXG 63.44
- BDRX 70.38
- Support Level
- ATXG $0.82
- BDRX $6.31
- Resistance Level
- ATXG $1.17
- BDRX $7.00
- Average True Range (ATR)
- ATXG 0.16
- BDRX 0.46
- MACD
- ATXG 0.00
- BDRX 0.05
- Stochastic Oscillator
- ATXG 56.90
- BDRX 87.56
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.